Pulmonary artery pressure correlates directly with spleen volume in non-splenectomized hemoglobin E/β-thalassemia patients

Acta Haematologica

Volumn 130, Issue 3, 2013, Pages 172-175

  Atichartakarn, Vichai ^a   Chuncharunee, Suporn ^a   Yamwong, Sukit ^a   Yingchoncharoen, Teerapat ^a   Jongjirasiri, Sutipong ^a   Archararit, Napaporn ^a   Udomsubpayakul, Umaporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN E; HEPATITIS B SURFACE ANTIGEN; LACTATE DEHYDROGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BETA THALASSEMIA; BLOOD TRANSFUSION; BLOOD VOLUME; CHELATION THERAPY; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; FERRITIN BLOOD LEVEL; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEMOGLOBIN E BETA THALASSEMIA; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERCOAGULABILITY; INFORMED CONSENT; INTRAVASCULAR HEMOLYSIS; IRON CHELATION; IRON THERAPY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ARTERY PRESSURE; MICROPARTICLE ENZYME IMMUNOASSAY; MOUTH HYGIENE; OUTPATIENT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; PULMONARY VALVE INSUFFICIENCY; SEROLOGY; SPINE FRACTURE; SPLEEN SIZE; SPLENECTOMY; SPLENOMEGALY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; ADULT; DISEASE SEVERITY; FEMALE; MALE;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBIN E; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PULMONARY ARTERY; SPLEEN;

EID: 84878357736     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000350644     Document Type: Article

References (21)

1. Aessopos A, Farmakis D, Karagiorga M, Voskaridou E, Loutradi A, Hatziliami A, Joussef J, Rombos J, Loukopoulos D: Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 2001; 97: 3411-3416.
2. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Bernice B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP: Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895.
3. Weatherall DJ: The thalassemias: disorders of globin synthesis; in Kaushansky K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT (eds): Williams Hematology, ed 8. New York, McGraw-Hill, 2010, pp 675-707.
4. Rich S: Pulmonary hypertension; in Bonow RO, Mann DL, Zipes DP, Libby P (eds): Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine, ed 9. Philadelphia, Elsevier Saunders, 2012, pp 1696-1718.
5. Atichartakarn V, Likittanasombat K, Chuncharunee S, Chandanamattha P, Worapongpaiboon S, Angchaisuksiri P, Aryurachai K: Pulmonary arterial hypertension in previously splenectomized patients with ?-thalassemic disorders. Int J Hematol 2003; 78: 139-145.
6. Chuncharunee S, Atichartakarn V, Archararit N, Archararit N, Udomsubpayakul U, Ingsathit A, Lee R, Tunhasiriwet A, Tanomsup S, Aryurachai K, Ungkanont A, Niparuck P, Angchaisuksiri P: Prevalence and predictors of pulmonary arterial hypertension in hemoglobin E/?-thalassemia patients (abstract 2015). Blood 2009; 114: 395.
7. Angchaisuksiri P, Atichartakarn V, Aryurachai K, Archararit N, Chuncharunee S, Tiraganjana A, Rattanasiri S: Hemostatic and thrombotic markers in patients with hemoglobin E/?-thalassemia disease. Am J Hematol 2007; 82: 1001-1004.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
9. Rudski LG, Lai WW, Afilalo J, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB: Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
10. Lithanatudom P, Leecharoenkiat A, Wannatung T, Wannatung T, Svasti S, Fucharoen S, Smith DR: A mechanism of ineffective erythropoiesis in ?-thalassemia/Hb E disease. Haematologica 2010; 95: 716-723.
11. Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD: Prevalence of thromboembolic events among 8, 860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Hemost 2006; 96: 488-491.
12. Castro O, Hoque M, Brown BD: Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood 2003; 101: 1257-1261.
13. Adedeji MO, Cespedes J, Allen K, Allen KK, Subramony C, Hughson MD: Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med 2001; 125: 1436-1441.
14. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
15. Setty BN, Rao KA, Stuart MJ: Thrombophilia in sickle cell disease: the red cell connection. Blood 2001; 98: 3228-3233.
16. Atichartakarn V, Angchaisuksiri P, Aryurachai K, Onpun S, Chuncharunee S, Thakkinstian A, Atamasirikul K: Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/?-thalassaemic patients. Br J Haematol 2002; 118: 893-898.
17. Ataga KI, Moore CG, Hillery CA, Jones S, Whinna HC, Strayhorn D, Sohier C, Hinderliter A, Parise LV, Orringer EP: Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica 2008; 93: 20-26.
18. Banyatsuppasin W, Butthep P, Atichartakarn V, Thakkinstian A, Archararit N, Pattanapanyasat K, Chuncharunee S: Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/?-thalassemia patients. Am J Hematol 2011; 86: 89-92.
19. Duke M, Abelman WH: The hemodynamic response to chronic anemia. Circulation 1969; 39: 503-515.
20. Eldor A, Rachmilewitz EA: The hypercoagulable state in thalassemia. Blood 2002; 99: 36-43.
21. Atichartakarn V, Chuncharunee S, Chandanamattha P, Likittanasombat K, Aryurachai K: Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/?-thalassemia patient. Blood 2004; 103: 2844-2846.